Role of lipocalin-2 in the development and progression of liver diseases / 临床肝胆病杂志
Journal of Clinical Hepatology
; (12): 2177-2181, 2022.
Article
in Zh
| WPRIM
| ID: wpr-942683
Responsible library:
WPRO
ABSTRACT
Lipocalin-2 (LCN2) is a secreted glycoprotein originally purified from mouse kidney cells infected with simian virus 40 and plays a key role in the control of cellular homeostasis during inflammation and the response to cellular stress or injury, and it is considered a potential biomarker for rheumatic diseases, cancer, liver diseases, and inflammatory diseases. Studies have shown that LCN2 is expressed in hepatic parenchymal and nonparenchymal cells and is secreted into the bloodstream, and it is closely associated with the development and progression of acute liver injury, liver cirrhosis, viral hepatitis, alcoholic liver disease, nonalcoholic fatty liver disease, and hepatocellular carcinoma. This article summarizes the animal experiments and clinical studies on the association of LCN2 with the pathogenesis of liver diseases, in order to provide new ideas and therapeutic targets for the prevention and treatment of liver diseases.
Full text:
1
Database:
WPRIM
Language:
Zh
Journal:
Journal of Clinical Hepatology
Year:
2022
Document type:
Article